Stephen is CardioLife’s Executive Chair, with 40 years of CEO and director experience across PwC, IBM, Cardno, DAI Capital and Eaton Capital. His background in MedTech M&A and capital raising provides governance and transactional depth through the Series A and subsequent value milestones.

Ross brings 30 years in medical devices to the CardioLife board, having served as a Director of Ventracor and ResMed and as Founder of Cardiex/Atcor. His Ventracor heritage provides direct continuity with the VentrAssist programme on which EasyHeart is built.

Andrew is a leading international corporate lawyer with 35 years chairing boards and advising on MedTech M&A. He provides the board with transactional and governance oversight appropriate to a cross-border capital raise and future exit.